Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PRPH
- Price
- 0.31
- Stock movement up
- +0.04 (15.33%)
- Company name
- ProPhase Labs Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 7.37M
- Ent value
- 60.55M
- Price/Sales
- 0.58
- Price/Book
- 0.19
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -45.70%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 44.90%
- 1 year return
- -94.97%
- 3 year return
- -64.96%
- 5 year return
- -30.48%
- 10 year return
- -14.40%
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PRPH does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.58 |
| Price to Book | 0.19 |
| EV to Sales | 4.75 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 23.87M |
| EPS (TTM) | -1.45 |
| FCF per share (TTM) | -0.87 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 12.75M |
| Gross profit (TTM) | -4.13M |
| Operating income (TTM) | -35.41M |
| Net income (TTM) | -27.76M |
| EPS (TTM) | -1.45 |
| EPS (1y forward) | -0.80 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -32.38% |
| Operating margin (TTM) | -277.69% |
| Profit margin (TTM) | -217.64% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 501.00K |
| Net receivables | 31.64M |
| Total current assets | 42.23M |
| Goodwill | 5.23M |
| Intangible assets | 10.40M |
| Property, plant and equipment | 18.09M |
| Total assets | 91.81M |
| Accounts payable | 15.46M |
| Short/Current long term debt | 29.59M |
| Total current liabilities | 28.70M |
| Total liabilities | 53.68M |
| Shareholder's equity | 38.13M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.18M |
| Capital expenditures (TTM) | 2.45M |
| Free cash flow (TTM) | -16.63M |
| Dividends paid (TTM) | 7.60M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -72.80% |
| Return on Assets | -30.23% |
| Return on Invested Capital | -42.68% |
| Cash Return on Invested Capital | -25.57% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.28 |
| Daily high | 0.33 |
| Daily low | 0.25 |
| Daily Volume | 1.13M |
| All-time high | 22.13 |
| 1y analyst estimate | 18.50 |
| Beta | -0.10 |
| EPS (TTM) | -1.45 |
| Dividend per share | - |
| Ex-div date | 24 May 2022 |
| Next earnings date | 7 May 2025 |
Downside potential
Loading...
Downside potential data
| PRPH | S&P500 | |
| Current price drop from All-time high | -98.61% | -12.89% |
| Highest price drop | -98.93% | -56.47% |
| Date of highest drop | 4 Feb 2025 | 9 Mar 2009 |
| Avg drop from high | -76.38% | -11.07% |
| Avg time to new high | 202 days | 12 days |
| Max time to new high | 6814 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
7.37M
Marketcap category
Small-cap
Description
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Employees
113
Website
Investor relations
-
SEC filings
CEO
Ted William Karkus
Country
USA
City
Doylestown
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page